Every Cure’s cover photo
Every Cure

Every Cure

Biotechnology

Philadelphia, PA 12,400 followers

Every Cure is leveraging AI to unlock the full potential of every drug to treat every disease it possibly can.

About us

Every Cure is a nonprofit organization dedicated to unlocking the full potential of every existing medicine to treat every disease possible. Repurposing existing drugs is the fastest and most efficient way to treat diseases with the greatest return on investment for saving lives. However, systemic barriers impede repurposing, so patients suffer while potential treatments are not fully utilized. Every Cure overcomes these barriers to systematically identify and advance promising repurposing opportunities and save lives. Every Cure is taking a revolutionary and disruptive approach to overcome these systemic barriers by developing a comprehensive, open-source data engine to generate predictive efficacy scores for all 3,000 drugs against all 12,000 diseases and rapidly advance treatments to patients. In partnership with academia, industry, and government, Every Cure is integrating proprietary and public data into a comprehensive dataset, optimizing AI ranking algorithms, validating the most promising drug-disease matches, performing trials, and ensuring patient access to effective therapies.

Website
EveryCure.org
Industry
Biotechnology
Company size
11-50 employees
Headquarters
Philadelphia, PA
Type
Nonprofit
Founded
2022
Specialties
biotechnology, artificial intelligence, drug development, drug repurposing, non-profit, medicine, and medtech

Locations

Employees at Every Cure

Updates

  • We’re proud to share that Every Cure just celebrated three years of pursuing our mission: saving and improving lives by unlocking the full potential of existing medicines. From one of the world’s most common cancers to one of the rarest diseases ever described, our team has been advancing overlooked treatments — not by inventing new drugs, but by finding new uses for the ones we already have. And now, our AI platform MATRIX — the engine that powers this work — has just been named a TIME Invention of the Year. MATRIX identifies both known but underutilized drug-disease connections and completely novel opportunities no one’s uncovered before. It’s not just about making predictions — it’s about translating them into real patient impact. We’re grateful for our incredible team, our supporters, and our funders like Advanced Research Projects Agency for Health (ARPA-H) who have made this possible. The next chapter is just beginning. Be sure to read the full TIME article to learn more about our work! https://lnkd.in/evZCeRx8 #DrugRepurposing #AIforGood #TIMEInventionOfTheYear #EveryCure #MATRIX #HealthcareInnovation #PatientImpact #NonprofitBiotech

  • Every Cure reposted this

    View profile for Reid Hoffman
    Reid Hoffman Reid Hoffman is an Influencer

    Co-Founder, LinkedIn, Manas AI & Inflection AI. Founding Team, PayPal. Author of Superagency. Podcaster of Possible and Masters of Scale.

    At 25, David Fajgenbaum, MD, MBA, MSc was told he was dying. But then he had an idea: What if there were drugs out there—ones already approved for use for other diseases—that could treat him? From his hospital bed after being read his last rites, David discovered the drug that saved his life: a treatment that was already on the market, available for doctors to prescribe, just not for his disease. Now, he's launched Every Cure to leverage AI and find new treatments and solutions from existing drugs to save others. I hope you find Aria and my conversation with David as inspiring as we did.  Everyone should know about the work he’s doing. People need to see the hope in AI. It can be, quite literally, life-changing.

  • Every Cure reposted this

    View profile for David Fajgenbaum, MD, MBA, MSc

    Physician-Scientist @ UPenn | Co-Founder & President @ Every Cure | Bestselling Author, Chasing My Cure | TIME100 Health | 2025 TED

    “Her little body was trembling so hard I could feel it through my arms. I tried to hold her still, whispering, “You’re okay, baby,” but I was crying too. Katie was only 18 months old when we first started noticing symptoms. At that age, she should have been learning to run, to play, to chase after her big brother. Instead, she was in and out of hospitals. Three major surgeries. Dozens of scans. So many hospitalizations I lost count. And still, no one knew what was wrong. We were fighting in the dark. Then one day, a doctor finally spoke the words I’ll never forget: Castleman disease. For years, we tried everything we could. Steroids. Targeted chemo. Each time hoping, praying, maybe this one would work. It felt like we were experimenting in the dark, like our little girl was a guinea pig in a world that didn’t yet know how to help her. I remember the moment when the doctors said they were out of options. There’s no way to describe that kind of fear — watching your child struggling and realizing medicine has no more answers. But then came a glimmer of hope. We connected with Dr. David Fajgenbaum and his team at the CDCN. He’d battled Castleman disease himself and survived. He suggested a drug called sirolimus, the same one that had saved his life. And somehow… it started to help Katie’s too. Today, Katie’s in middle school. She’s an incredible dancer and she’s thriving. Dance has become her outlet, her joy, and her strength. She dances not just because she loves it, but because she can — because her body that once failed her now lets her express every ounce of her courage and resilience through movement. Katie has been fighting this disease since before she could speak. But she’s fluent now in courage, in grace, in medical routines most adults couldn’t handle. She’s the strongest person I know not just because she survived, but because she’s thriving, leading with joy, inspiring others. She’s living proof that even the smallest warriors can grow into the fiercest lights.” - Mileva Repasky, the incredibly strong mother of Katie and a leader of Castleman Disease Collaborative Network for more than a decade

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • We're excited to announce a Strategic Collaboration with Predictive Oncology to Pursue Drug Repurposing for Cancer Patients! The intersecting interests and expertise of our two organizations perfectly aligns with our drug repurposing efforts, seeking to identify treatments to be used when standard treatments options have been exhausted, while also promoting equitable and economically feasible healthcare. Collaborating with Predictive Oncology on this endeavor not only supports our mission but advances our cause. Click the link below to read the full press release! https://lnkd.in/e-idCRVJ

  • Every Cure reposted this

    View profile for David Fajgenbaum, MD, MBA, MSc

    Physician-Scientist @ UPenn | Co-Founder & President @ Every Cure | Bestselling Author, Chasing My Cure | TIME100 Health | 2025 TED

    So proud that we’ve been selected to the 2025 TIME100 Next list, recognizing the top 100 “emerging leaders from around the world who are shaping the future.” This recognition is a testament to our amazing teams at Every CurePenn Medicine, University of Pennsylvania Health System, and Castleman Disease Collaborative Network, our incredible partners, and all of you who have helped to advance our mission and demonstrate the life-saving impact of our work! While we are thrilled for the incredible awareness and humbled to be included alongside these leaders, our focus remains unwavering: to save and improve lives by repurposing drugs no matter how rare or common the disease or how old or overlooked the drug may be. Thank you to everyone helping us advance this mission. I hope you’ll click the link below to read the full article written by Priscilla Chan from the Chan Zuckerberg Initiative! https://lnkd.in/g-9_Um29 #TIME100NEXT

    • No alternative text description for this image
  • Every Cure reposted this

    View profile for David Fajgenbaum, MD, MBA, MSc

    Physician-Scientist @ UPenn | Co-Founder & President @ Every Cure | Bestselling Author, Chasing My Cure | TIME100 Health | 2025 TED

    During my TED talk I imagined I was talking to my mom who I haven’t seen her in 20 years since she passed away from cancer. I promised her I’d dedicate my life to finding treatments for patients like her. And this TED Talk was my way of telling her what I’ve been working on all these years. Every second I spoke, I thought about the patients all over the world who could benefit from the awareness this talk might spark. It was nerve-wracking but so worth it. If you haven’t seen it yet, I hope you’ll take a few minutes to watch by clicking the link below. https://lnkd.in/evWHPTHe #doctor #medicine #tedtalk

  • Every Cure reposted this

    View profile for David Fajgenbaum, MD, MBA, MSc

    Physician-Scientist @ UPenn | Co-Founder & President @ Every Cure | Bestselling Author, Chasing My Cure | TIME100 Health | 2025 TED

    Hope alone won’t save lives. But hope with action just might. I had a great time sitting down with Celina de Sola, Co-founder and President of Glasswing International to discuss how to turn setbacks into motivation as a part of TED Conferences Intersections Series. Click the link to watch our full conversation! https://lnkd.in/eAfk3Pr8 #setbacks #motivation #doctor

  • Every Cure reposted this

    View profile for David Fajgenbaum, MD, MBA, MSc

    Physician-Scientist @ UPenn | Co-Founder & President @ Every Cure | Bestselling Author, Chasing My Cure | TIME100 Health | 2025 TED

    “One month I won the state championship in track. The next, I was lying in a hospital bed unable to eat, walk, or even get out of bed on my own. It started with stomach pain so sharp I had to be rushed to the ER. I thought maybe it was something simple—appendix, food poisoning, something they could fix. But after they did a surgery, the pain didn’t stop. My body was on fire, my belly filled with fluid, my organs started shutting down. The doctors weren’t sure what was happening. They ruled out cancer, but nothing made sense. Weeks went by, and I grew weaker. My muscles wasted away. I couldn’t feed myself. I couldn’t stand. For a 15-year-old who lived for football, basketball, and track, it felt like my life had ended. I also knew the my life could actually end at any time. My mom was amazing. Even with everything going on, she was constantly there for me. Finally, after a few months, they thought it might be Castleman disease — it was so rare that none of my doctors had ever seen it before. They had heard about Dr Fajgenbaum’s work and got in touch with him right away. Hearing the word “rare” scared me more than anything. Would I survive? Would I ever get back to school? Would I ever feel like myself again? Dr Fajgenbaum’s recommended a treatment that he and the CDCN had helped to get approved for Castleman’s. I’ll never forget the feeling when it started to work. Little by little, I pushed myself. I got out of bed. I walked. I fought to catch up in school. By the time I returned, I’d already fully caught up on my math course on my own. Sports gave me discipline, but Castleman gave me perspective. I learned I was more than an athlete. I became someone others could look up to. A leader, even when no one was watching. Today, I’m a freshman at Concordia University in St. Paul, majoring in communications with a minor in marketing and sports management. Someday, I want to open a gym for student athletes who’ve been knocked down like I was—because I know what it feels like to lose everything and fight your way back.” - Avion Dent Every Cure Castleman Disease Collaborative Network #doctor #medicine #raredisease #drugrepurposing

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Every Cure reposted this

    View profile for David Fajgenbaum, MD, MBA, MSc

    Physician-Scientist @ UPenn | Co-Founder & President @ Every Cure | Bestselling Author, Chasing My Cure | TIME100 Health | 2025 TED

    The moment my life changed forever was when I realized that hope alone wouldn’t save my life. If I wanted a chance to survive, I needed to turn that hope into action. Today our TED talk goes live on Youtube that could help us save more patients. You can click the link below to watch the talk: https://lnkd.in/edQzCwWR Please watch, like, repost, and share the talk as far and wide as you can to help us on our mission to save and improve lives by repurposing drugs! #doctor #medicine #tedtalk

  • Every Cure reposted this

    View profile for David Fajgenbaum, MD, MBA, MSc

    Physician-Scientist @ UPenn | Co-Founder & President @ Every Cure | Bestselling Author, Chasing My Cure | TIME100 Health | 2025 TED

    “For years, my son couldn’t tell me he loved me. He couldn’t share any feelings or statements with me. He could only repeat back the words I said to him. Every night, we stayed up late searching the internet, desperate for anything that might give our son a voice. That’s when we kept seeing the same name: Dr. Richard Frye. And a test called the folate receptor autoantibody test. We thought, maybe this is it. It wasn’t easy. It took months just to find a doctor willing to order the test. But finally, he got the test and it came back positive, meaning he had something called cerebral folate deficiency which can sometimes co-occur with autism spectrum disorder. When Junior finally started treatment with leucovorin to address the cerebral folate deficiency, we had no idea what to expect. Within weeks, he began to share his thoughts and then one day, out of nowhere, he looked up at me and said: “All right, bye Dad, I love you.” Unprompted. Clear as day. That moment was everything. After years of searching, fighting, and hoping—we finally had a breakthrough. A treatment that gave our son his voice .  A chance to hear him say he loved us.” - Ryan Baldridge, father of “Junior” who I shared about in my TED talk I felt so compelled to share this story of how cerebral folate deficiency could be responsible for Ryan’s speech challenges and how this simple vitamin derivative, leucovorin, could help to address it. This is why we started Every Cure. To advance treatments like this to patients who can benefit from them.

Similar pages

Browse jobs

Funding

Every Cure 2 total rounds

Last Round

Grant

US$ 60.0M

See more info on crunchbase